SCARB2 and hepatocellular carcinoma: The proportion of EpCAM, CD133, or CD24 positive cells significantly decreased in CreAlbScarb2F/FMyc mice than that in CreAlbMyc mice, demonstrating that knockout of Scarb2 had effect on the HCC initiating state (Fig. 2g).